Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 12:27 AM
Ignite Modification Date: 2025-12-25 @ 12:27 AM
NCT ID: NCT02049567
Eligibility Criteria: Key Inclusion Criteria: * Eligible for primary intraocular lens implantation for the correction of aphakia following cataract extraction; * Best corrected distance visual acuity worse than 20/40 either with or without a glare source present (e.g. Brightness Acuity Tester); * Less than or equal to 1.0 diopter (D) of preoperative keratometric astigmatism; * Willing and able to comply with schedule for follow-up visits for 36 months after surgery. * Other protocol-defined inclusion criteria may apply. Key Exclusion Criteria: * Systemic disease that could increase the operative risk or confound the outcome (e.g. autoimmune disease, diabetes); * Taking systemic medications that may confound the outcome or increase the risk to the subject; * Ocular conditions that may predispose for future complications; * Previous intraocular or corneal surgery that might confound the outcome of the investigation or increase the risk to the subject; * Pregnant, lactating during the course of the investigation, or with another condition associated with fluctuation of hormones that could lead to refractive changes; * Diagnosed degenerative visual disorders (e.g. macular degeneration or other retinal disorders) that are predicted to cause future best corrected visual acuity loss worse than 20/40. * Other protocol-defined exclusion criteria may apply.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 50 Years
Study: NCT02049567
Study Brief:
Protocol Section: NCT02049567